| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $9.01M | - | |
| Dir | 135.9K | $5.29M | - | |
| VP | 90.4K | $3.52M | -9,000 | |
| CFO | 36.7K | $1.43M | - | |
| Dir | 35.8K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 7, 2020 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $14.63 | $731,265.00 | -6.2% | |
| May 5, 2020 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $14.06 | $351,425.00 | -11.0% | |
| Apr 2, 2020 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $13.79 | $689,500.00 | -6.2% | |
| Mar 26, 2020 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 75,000 | $14.36 | $1,077,225.00 | -9.0% | |
| Mar 24, 2020 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $13.91 | $347,717.50 | -11.0% | |
| Mar 19, 2020 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 75,000 | $14.47 | $1,085,427.60 | -3.1% | |
| Mar 17, 2020 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $13.54 | $338,506.33 | -5.8% | |
| Feb 24, 2020 | Wysenski Nancy | Director | Buy | 6,940 | $19.65 | $136,371.00 | +161.3% | |
| Nov 14, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $19.50 | $1,950,000.00 | -12.2% | |
| Nov 13, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $19.70 | $394,056.00 | -9.8% |